News
Hesai Technology (Nasdaq: HSAI), a global leader in lidar solutions, will attend IAA Mobility 2025, the world's leading ...
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESS Newswire / August 14, 2025 / Lobe Sciences Ltd. ("Lobe Sciences" or the "Compa ...
VANCOUVER, BC / ACCESS Newswire / August 14, 2025 / Right Season Investments Corp. (TSXV:LITT), ("Right Season" or the "Company") is pleased to announce that it will move forward with the implementati ...
Letter from the CEO about Q2 2025 Financial Reporting JACKSON, WY / ACCESS Newswire / August 14, 2025 /Fellow Shareholders,As we close the second quarter of 2025, I want ...
HOUSTON, TX / ACCESS Newswire / August 14, 2025 / PEDEVCO Corp. (NYSE American:PED) ("PEDEVCO" or the "Company"), an energy company engaged in the acquisition and development of strategic, high growth ...
BUUU Group Limited (Nasdaq: BUUU) (the "Company"), an established meetings, incentives, conferences and exhibitions ("MICE") solutions provider based in ...
Company exits low-margin product lines, invests in higher-margin, innovative CEA-informed, better-for-you shelf-stable products, and expands global reach Conference Call to Be Held Today at 8:00 ...
CALGARY, AB / ACCESS Newswire / August 14, 2025 / Appulse Corporation ("Appulse" or "the Corporation") today reported financial results for the six-month period ended June 30, 2025.The financial posit ...
BOCA RATON, FL / ACCESS Newswire / August 14, 2025 / Greenlane Holdings, Inc. ("Greenlane" or the "Company") (Nasdaq:GNLN), one of the premier global sellers of premium cannabis accessories, child-res ...
TULSA, OKLAHOMA / ACCESS Newswire / August 14, 2025 / ClearSign Technologies Corporation (Nasdaq:CLIR) ("ClearSign" or the "Company"), a leader in advanced combustion and sensing technologies that hel ...
FAIRFAX, VA / ACCESS Newswire / August 14, 2025 / WidePoint Corporation(NYSE American:WYY), an innovative leader in enterprise cybersecurity and mobile technology, reported results for the second quar ...
Following positive preclinical data, simufilam development to advance with a clinical study expected to begin in H1 2026 for the potential treatment of TSC-related epilepsyRecent appointment of experi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results